Arcus Biosciences, Inc. (RCUS)

NYSE: RCUS · Real-Time Price · USD

21.91

+0.38 (1.76%)

At close: Dec 15, 2025, 4:00 PM EST

21.75

-0.16 (-0.73%)

Pre-market: Dec 16, 2025, 8:01 AM EST

Arcus Biosciences Revenue by Segment

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
License and Devlopment Services	241.00M	117.00M	232.00M	226.00M	207.00M	198.00M	80.00M	84.00M	-	-	-	-	-	-
License and Devlopment Services Growth	16.43%	-40.91%	190.00%	169.05%	141.42%	137.31%	7.56%	-78.64%	-	-	-	-	-	-
Other Collaboration	31.00M	34.00M	36.00M	37.00M	40.00M	39.00M	37.00M	36.00M
Other Collaboration Growth	-22.50%	-12.82%	-2.70%	2.78%	11.61%	8.62%	-2.56%	-8.85%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.